Cardiology Highlight Reel 2015 – Diabetes and CVD
Details & Video
Learn about the first clinical trial in history to show a CV benefit of a glucose-lowering drug!
Join Dr. Darren McGuire in conversation discussing the latest clinical trials of glucose-lowering agents for cardiovascular safety and efficacy.
The Cardiology Highlight Reel 2015 series engages world-renowned experts in conversation about the most important advances in cardiovascular medicine in 2015. Presented in short interviews, this program is a must-see for all clinicians managing patients with, or at risk for, cardiovascular disease.
In this segment, Dr. Darren McGuire discusses the latest clinical trials of glucose-lowering agents for cardiovascular safety and efficacy.
Participate in this eCME program and stay informed!
This program is eligible for MOC RCPSC, Section 2 credits or you are eligible to claim up to 5 Mainpro+ certified credits by completing the CFPC’s Linking Learning to practice exercise.
You will receive your Certificate of Completion following participation in the interactive program elements located under the “Certificate” tab in the program player window. A link to the Linking Learning to Practice exercise on the CFPC website will be included in your certificate.
Potential for conflicts of interest:
Some speakers in this program have received payment/funding from the organizations supporting this program.
Speaker disclosures will be declared within the presentations.
Milan Gupta, MD, FRCPC, FACC
Associate Clinical Professor, Dep’t of Medicine
McMaster UniversityAssistant Professor, Dep’t of Medicine
University of TorontoMedical Director
Canadian Cardiovascular Research Network
Narendra Singh, MD, FRCPC, FACC, FAHA
Director, Clinical Research
Atlanta Heart SpecialistsClinical Assistant Professor
Georgia Regents University
Darren McGuire, MD, MHSc
Professor of Medicine, University of Texas
Southwestern Medical Center
|A paradigm shift||1 min|